Literature DB >> 6232245

A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry.

F Koning, I Schreuder, M Giphart, H Bruning.   

Abstract

A mouse monoclonal antibody (7.3.19.1) was produced which reacts with class II molecules on B cells and monocytes of DR3, DR5, and/or DRw6 positive donors only. Using this moab and two others, three different groups of class II molecules could be identified. Furthermore, a differential precipitation pattern was found which correlates with a DR-related variable expression of the MT2-like polymorphic determinants on the cell surface. Addition of 7.3.19.1 to MLCs did not result in significant inhibition in controls to the two other moabs tested. Normal CTL activity was found in such a stimulated responder population.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6232245     DOI： 10.1016/0198-8859(84)90027-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN： 0198-8859            Impact factor:   2.850


  18 in total

1.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

Authors:  E Mellins; B Arp; D Singh; B Carreno; L Smith; A H Johnson; D Pious
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Polymorphisms within the HLA-DRw6 haplotype. II. Protein charge heterogeneity reflects MLC subtyping of HLA-DRw6 homozygous cells.

Authors:  M L Bosch; A Termijtelen; R Gerrets; G M Schreuder; R E Bontrop; M J Giphart
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  Recognition of class II molecules by human T cells. I. Analysis of epitopes of DR and DQ molecules in a DRw11, DRw52, DQw3 haplotype.

Authors:  L K Myers; E J Ball; G Nuñez; P Stastny
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.

Authors:  R Bontrop; M Tilanus; M Mikulski; M van Eggermond; A Termijtelen; M Giphart
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Twenty-six DR beta and 16 DQ beta chain IEF variants and their associated HLA-DR, HLA-DQ, and HLA-Dw specificities.

Authors:  S Rodriguez de Cordoba; P Marshall; P Rubinstein
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52.

Authors:  F A Verreck; A van de Poel; J W Drijfhout; R Amons; J E Coligan; F Konig
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.

Authors:  A N McKenzie; J A Culpepper; R de Waal Malefyt; F Brière; J Punnonen; G Aversa; A Sato; W Dang; B G Cocks; S Menon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.

Authors:  R E Bontrop; D G Elferink; N Otting; M Jonker; R R de Vries
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.

Authors:  I Hauber; H Gulle; H M Wolf; M Maris; H Eggenbauer; M M Eibl
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.